Markets › News › Clinical Trials

Clinical Trials Crypto News

Clinical Trials crypto news from Token Times: 2 original briefs, each synthesised from across 50+ outlets, cross-checked for agreement on the key figures, enriched with live market data and Bitcoin-timestamped for provenance. The latest Clinical Trials developments are below — updated hourly, with the data context no single outlet carries.

BitcoinEthereumRegulationDeFiStablecoinsMarketsAltcoinsMacroInstitutionalTechnologyExchanges
TechnologyOctober 21, 2026·1 min read 2 sources
OpenAI Expands AI Drug Development with Orchestra Acquisition

OpenAI acquires Orchestra Bio to integrate AI agents for managing clinical trial delays into its Rosalind platform.

MarketsOctober 16, 2026·1 min read 2 sources
ImmunityBio Stock Falls Despite Promising Bladder Cancer Treatment Results

ImmunityBio's ANKTIVA shows strong efficacy in bladder cancer trials, yet the company's stock drops 7.25%.

← All crypto news